Tadatoshi Takayama

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy

Hiroshi Imamura, Yutaka Matsuyama, Eiji Tanaka et al. · Journal of Hepatology · 2003 · 1.6K citations

Medicine, Oncology, Carcinogenesis +16

Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial

Jordi Bruix, Tadatoshi Takayama, Vincenzo Mazzaferro et al. · The Lancet Oncology · 2015 · 1.1K citations

Medicine, Oncology, Surgery +17

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

Tadatoshi Takayama, Teruaki Sekine, Masatoshi Makuuchi et al. · The Lancet · 2000 · 848 citations

Medicine, Immunology, Oncology +10

Trans-ancestry mutational landscape of hepatocellular carcinoma genomes

Yasushi Totoki, Kenji Tatsuno, Kyle R. Covington et al. · Nature Genetics · 2014 · 779 citations

Medicine, Genetics, Molecular Genetics +14

Extension of the Frontiers of Surgical Indications in the Treatment of Liver Metastases From Colorectal Cancer

Masami Minagawa, Masatoshi Makuuchi, Tadatoshi Takayama et al. · Annals of Surgery · 2000 · 672 citations · Full text

Medicine, Oncology, Surgery +17